Hypertension Trial, Recruiting NCT06841575 Sponsor: Duke University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06841575
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 – Healthy Adults:

  • You are 18 years of age or older
  • You are generally healthy with no known eye problems other than needing glasses or contacts
  • You are willing and able to agree to take part in the study

Group 2 – Adult Eye Clinic Patients:

  • You are 18 years of age or older and are a patient at Duke Eye Center
  • Your doctor is aware of the study and is happy for the study team to contact you
  • You are willing and able to agree to take part in the study

Group 3 – Children Seen at Eye Clinics:

  • The child is under 18 years of age and is a patient at Duke Eye Center, or is having a medically necessary exam under anaesthesia at Duke Eye Center
  • The child's parent or legal guardian is willing and able to give consent on the child's behalf
  • The child's doctor is aware of the study and is happy for the study team to contact the parent or guardian

Who may not be able to join:

Group 1 – Healthy Adults:

  • You are a student or employee directly supervised by the researchers running this trial
  • You have had previous problems with eye-dilating drops
  • You are pregnant and would be receiving eye-dilating drops as part of the study

Group 2 – Adult Eye Clinic Patients:

  • You have a health or eye condition (such as a cloudy cornea or cataracts) that prevents a standard eye exam or retinal imaging from being carried out

Group 3 – Children Seen at Eye Clinics:

  • The child's parent or legal guardian is unwilling or unable to give consent
  • The child has a health or eye condition (such as a cloudy cornea or cataracts) that prevents a standard eye exam or retinal imaging from being carried out

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xi Chen, MD, PhD, Duke University

Phone: (919) 684-8434

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
23 March 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants with abnormal retinal microanatomy; Severity of abnormal retinal microanatomy; Retinal thickness (microns) at the fovea and surrounding optic nerve as measured by OCT analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov